Was Hormel’s Q2 Earnings Report the Turnaround Investors Needed?
For the better part of three years, Hormel Foods Corp. (NYSE: HRL) investors have been asked to be patient. Patient through the SPAM maker's painful slide from a $45 stock to the low $20s. Patient through missed earnings quarters, goodwill write-downs, and a turkey business that
For the better part of three years, Hormel Foods Corp. (NYSE: HRL) investors have been asked to be patient. Patient through the SPAM maker's painful slide from a $45 stock to the low $20s. Patient through missed earnings quarters, goodwill write-downs, and a turkey business that